HRP20181726T1 - Neinvazivno dijagnosticiranje raka - Google Patents

Neinvazivno dijagnosticiranje raka

Info

Publication number
HRP20181726T1
HRP20181726T1 HRP20181726TT HRP20181726T HRP20181726T1 HR P20181726 T1 HRP20181726 T1 HR P20181726T1 HR P20181726T T HRP20181726T T HR P20181726TT HR P20181726 T HRP20181726 T HR P20181726T HR P20181726 T1 HRP20181726 T1 HR P20181726T1
Authority
HR
Croatia
Prior art keywords
cancer diagnosis
invasive cancer
invasive
diagnosis
cancer
Prior art date
Application number
HRP20181726TT
Other languages
English (en)
Inventor
Robert Zeillinger
Original Assignee
SPEISER, Paul
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SPEISER, Paul filed Critical SPEISER, Paul
Publication of HRP20181726T1 publication Critical patent/HRP20181726T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
HRP20181726TT 2012-01-31 2018-10-22 Neinvazivno dijagnosticiranje raka HRP20181726T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12153340 2012-01-31
EP13701662.2A EP2809801B1 (en) 2012-01-31 2013-01-31 Non-invasive cancer diagnosis
PCT/EP2013/051899 WO2013113816A1 (en) 2012-01-31 2013-01-31 Non-invasive cancer diagnosis

Publications (1)

Publication Number Publication Date
HRP20181726T1 true HRP20181726T1 (hr) 2018-12-28

Family

ID=47624102

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181726TT HRP20181726T1 (hr) 2012-01-31 2018-10-22 Neinvazivno dijagnosticiranje raka

Country Status (11)

Country Link
US (1) US9493839B2 (hr)
EP (1) EP2809801B1 (hr)
CA (1) CA2863144A1 (hr)
DK (1) DK2809801T3 (hr)
ES (1) ES2691404T3 (hr)
HR (1) HRP20181726T1 (hr)
PL (1) PL2809801T3 (hr)
PT (1) PT2809801T (hr)
SI (1) SI2809801T1 (hr)
TR (1) TR201815847T4 (hr)
WO (1) WO2013113816A1 (hr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2824524C (en) 2011-01-25 2017-10-17 Nvision Medical Corporation Systems and methods for maintaining a narrow body lumen
US9476095B2 (en) 2011-04-15 2016-10-25 The Johns Hopkins University Safe sequencing system
CN104956225B (zh) 2012-10-29 2018-10-02 约翰·霍普金斯大学 卵巢和子宫内膜癌的帕帕尼科拉乌测试
US10639016B2 (en) 2013-02-01 2020-05-05 Boston Scientific Scimed, Inc. Methods and devices for Fallopian tube diagnostics
US11179143B2 (en) 2013-02-01 2021-11-23 Boston Scientific Scimed, Inc. Systems, methods, and devices for fallopian tube diagnostics
CA2899881A1 (en) 2013-02-01 2014-08-07 Nvision Medical Corporation Methods and devices for fallopian tube diagnostics
US11291434B2 (en) 2013-02-01 2022-04-05 Nvision Medical Corporation Systems, methods, and devices for fallopian tube diagnostics
US11286531B2 (en) 2015-08-11 2022-03-29 The Johns Hopkins University Assaying ovarian cyst fluid
US20170327898A1 (en) * 2016-05-16 2017-11-16 The Johns Hopkins University Ovarian carcinoma detection and prophylaxis
CN107419001A (zh) * 2016-05-23 2017-12-01 益善生物技术股份有限公司 Brca1、pten基因异常检测试剂盒及检测方法
WO2017220782A1 (en) * 2016-06-24 2017-12-28 Molecular Health Gmbh Screening method for endometrial cancer
EP3665308A1 (en) * 2017-08-07 2020-06-17 The Johns Hopkins University Methods and materials for assessing and treating cancer
CA3072819A1 (en) 2017-10-27 2019-05-02 Boston Scientific Scimed, Inc. Cell collection and preparation devices and methods
CN111440865B (zh) * 2019-01-17 2023-08-01 中山大学附属第六医院 Fat3基因甲基化检测试剂在制备结直肠癌预后诊断试剂中的应用
CN115418340A (zh) * 2022-06-09 2022-12-02 中南大学湘雅医院 人宫腔灌洗液来源的子宫内膜类器官的培养方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
EP1030934A4 (en) 1997-11-10 2004-03-17 Univ California BIOCHEMICAL METHODS FOR DETECTION OF DYSPLASIA AND Cervical CANCER
JP2000166557A (ja) * 1998-09-29 2000-06-20 Sumitomo Electric Ind Ltd 染色体異常の検出による子宮内膜癌の診断方法
WO2001070979A2 (en) * 2000-03-21 2001-09-27 Millennium Pharmaceuticals, Inc. Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
WO2001075177A2 (en) 2000-04-03 2001-10-11 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tumor markers in ovarian cancer
WO2002046765A2 (en) * 2000-11-08 2002-06-13 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
EP2036557B1 (en) * 2006-05-18 2015-10-21 Eisai R&D Management Co., Ltd. Antitumor agent for thyroid cancer
WO2008031228A1 (en) * 2006-09-15 2008-03-20 The Governors Of The University Of Alberta Automated fish analysis, circulating microfluidic chip, and method for immobilizing cells to a microfluidic chip
WO2009006543A1 (en) * 2007-07-02 2009-01-08 Euclid Diagnostics Llc Methods for evaluating the methylation status of a polynucleotide

Also Published As

Publication number Publication date
DK2809801T3 (en) 2018-11-12
SI2809801T1 (sl) 2018-12-31
PT2809801T (pt) 2018-11-20
US9493839B2 (en) 2016-11-15
PL2809801T3 (pl) 2018-12-31
EP2809801B1 (en) 2018-07-25
EP2809801A1 (en) 2014-12-10
US20140011199A1 (en) 2014-01-09
ES2691404T3 (es) 2018-11-27
CA2863144A1 (en) 2013-08-08
TR201815847T4 (tr) 2018-11-21
WO2013113816A1 (en) 2013-08-08

Similar Documents

Publication Publication Date Title
HRP20181726T1 (hr) Neinvazivno dijagnosticiranje raka
IL267242B (en) Cancer treatment
EP2878272A4 (en) ULTRASOUND ENDOSCOPE
EP2815691A4 (en) ENDOSCOPE
EP2719338A4 (en) ULTRASOUND ENDOSCOPE
EP2820999A4 (en) ENDOSCOPE
EP2692278A4 (en) Borescope
EP2837320A4 (en) Borescope
EP2805664A4 (en) Borescope
EP2656779A4 (en) ENDOSCOPE
EP2707710A4 (en) DIAGNOSIS OF CANCER
EP2835093A4 (en) ENDOSCOPE
EP2740411A4 (en) ULTRASOUND ENDOSCOPE
EP2799000A4 (en) ENDOSCOPE
EP2735260A4 (en) ENDOSCOPE
GB2500893B (en) Spirometer
EP2856924A4 (en) Borescope
SG11201502499UA (en) Cancer diagnosis device
HK1210023A1 (en) Cancer treatment
EP2759250A4 (en) ENDOSCOPE
HK1200723A1 (en) Pharmaceutical diagnostic
EP2721991A4 (en) ENDOSCOPE
GB201215502D0 (en) Medical use
GB201222563D0 (en) Cancer treatment
IL229109B (en) Cancer diagnosis